Neoadjuvant PD-1 blockade combined with chemotherapy is not superior to neoadjuvant chemotherapy alone in resectable locally advanced esophageal carcinoma

BACKGROUND: Neoadjuvant chemotherapy (nCT) or neoadjuvant chemoradiotherapy followed by surgery has been recommended as standard treatment in patients with locally advanced esophageal cancer (LAEC). But the risk of tumor recurrence still remained, and many patients refused or abandoned radiotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Daoan, Zhao, Weiqing, Chen, Rui, Li, Dong, Tang, Shuxian, Fang, Cheng, Ji, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896760/
https://www.ncbi.nlm.nih.gov/pubmed/36737768
http://dx.doi.org/10.1186/s12957-023-02915-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896760/
https://www.ncbi.nlm.nih.gov/pubmed/36737768
http://dx.doi.org/10.1186/s12957-023-02915-z

Ejemplares similares